生命保险申请者和美国人口中高BMI的死亡风险
相关实验视频
Updated: Jan 15, 2026

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
27.7K
Journal of insurance medicine (New York, N.Y.)
|October 11, 2025
概括
高体重指数 (BMI) 会增加死亡风险,但当考虑相关的健康状况时,这种影响会显著减少. 这一发现适用于生命保险申请人和国家健康和营养检查调查 (NHANES) 参与者.
科学领域:
- 流行病学 流行病学
- 公共卫生 公共卫生
- 生物统计学 生物统计学
背景情况:
- 高体重指数 (BMI) 是已知的所有原因和心血管死亡率增加的风险因素.
- 计算BMI相关疾病对死亡风险的确切影响尚未完全理解.
研究的目的:
- 量化生命保险申请人和NHANES参与者高BMI相关的死亡风险.
- 评估控制与BMI相关的疾病和疾病如何影响这种死亡风险.
主要方法:
- 利用来自700多万生命保险申请人和23,486名NHANES参与者的数据的考克斯比例危险模型.
- 分析BMI作为连续和分类变量.
- 构建了连续的模型,控制年龄,性别,疾病状态 (高血压,糖尿病,心脏病),肝功能,血压,功能和血红蛋白A1c.
主要成果:
- 高BMI与死亡风险之间的关联在单变量模型中最强,并且随着对相关条件的连续调整而减少.
- 在人寿保险数据中,显著的死亡风险持续在BMI 35以上;在NHANES数据中,它持续在BMI 40以上.
- 持续的BMI危险在CRL数据中对两性都保持显著,但在最终的NHANES模型中仅对男性有显著意义.
结论:
- 当考虑相关疾病和疾病时,高BMI的死亡率效应大大减弱.
- 这强调了管理高BMI个体的并发症的重要性,以减轻死亡风险.
更多相关视频
07:44Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
1.7K
14:56Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
Published on: May 6, 2022
5.0K
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients
222
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
222
Actuarial Approach
286
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
286
Applications of Life Tables
323
Life tables are versatile across various fields, providing a quantitative basis for analyzing mortality and survival rates. Whether used by demographers, actuaries, epidemiologists, or sociologists, life tables offer valuable insights into the dynamics of life and death, facilitating informed decisions in public health, insurance, conservation, and beyond. Their broad applicability highlights the interconnectedness of demographic data with practical outcomes in everyday life and strategic...
323
Life Tables
499
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
499
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
246
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
246